Price
Target price
€25.60
€25.60
0.390%
0.1
0.390%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Schott Pharma & Co. Kgaa
sharewise wants to provide you with the best news and tools for Schott Pharma & Co. Kgaa, so we directly link to the best financial data sources.
Financials
News
EQS-News: SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO
EQS-News: SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO
EQS-News: SCHOTT Pharma invests in sterile cartridge production in Hungary
EQS-News: SCHOTT Pharma invests in sterile cartridge production in Hungary
EQS-News: SCHOTT Pharma delivers strong second quarter of fiscal year 2025
EQS-News: SCHOTT Pharma delivers strong second quarter of fiscal year 2025
EQS-News: SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla
EQS-News: SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture in India; TPG makes strategic investment in SCHOTT Poonawalla
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations
EQS-News: Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
EQS-News: Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
EQS-News: SCHOTT Pharma records good start into fiscal year and confirms full year outlook
EQS-News: SCHOTT Pharma records good start into fiscal year and confirms full year outlook
EQS-News: SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items
EQS-News: SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items